Transcervical Sterilization

Paula M Castaño; Lola Adekunle

doi:10.1055/s-0030-1248134

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2010; 28(2): 103-109
DOI: 10.1055/s-0030-1248134

Transcervical Sterilization

Paula M. Castaño¹ , Lola Adekunle¹

¹Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York

Abstract

ABSTRACT

Sterilization is frequently chosen as a method of permanent contraception. Traditional approaches involve surgery under anesthesia in an operating room and are associated with a recovery period and scars. Transcervical sterilization is an incision-free, minimally invasive approach to sterilization. When compared with laparoscopic surgery, transcervical hysteroscopic sterilization does not need to be performed in an operating room, requires less anesthesia, has a shorter recovery period, and is more cost effective. The Essure Permanent Birth Control System (Conceptus, Inc., Mountain View, CA) and Adiana Permanent Contraception System (Hologic, Inc., Bedford, MA) are two available hysteroscopic sterilization techniques. They cause fibrosis and tubal occlusion over a 3-month period so women must use an alternative form of contraception during the first 3 months. A 3-month hysterosalpingogram confirms successful placement and tubal occlusion. Transcervical sterilization is similarly effective to other sterilization methods and is satisfactory to women.

KEYWORDS

Sterilization - transcervical - hysteroscopic - Essure - Adiana

Full Text

References

REFERENCES

1 Dowbiggin I. The Sterilization Movement and Global Fertility in the Twentieth Century. New York, NY; Oxford University Press 2008: 21-23
2 Chandra A, Martinez G M, Mosher W D, Abma J C, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005; (25) 1-160
3 Westhoff C, Davis A. Tubal sterilization: focus on the U.S. experience. Fertil Steril. 2000; 73(5) 913-922
4 MacKay A P, Kieke Jr B A, Koonin L M, Beattie K. Tubal sterilization in the United States, 1994–1996. Fam Plann Perspect. 2001; 33(4) 161-165
5 Barone M A, Hutchinson P L, Johnson C H, Hsia J, Wheeler J. Vasectomy in the United States, 2002. J Urol. 2006; 176(1) 232-236, discussion 236
6 Jamieson D J, Hillis S D, Duerr A, Marchbanks P A, Costello C, Peterson H B. Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol. 2000; 96(6) 997-1002
7 Peterson H B, Xia Z, Hughes J M, Wilcox L S, Tylor L R, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996; 174(4) 1161-1168, discussion 1168–1170
8 Hieu D T, Tan T T, Tan D N, Nguyet P T, Than P, Vinh D Q. 31,781 cases of non-surgical female sterilisation with quinacrine pellets in Vietnam. Lancet. 1993; 342(8865) 213-217
9 Agoestina T, Hoesni R HM, Purwara B H et al.. Randomized trial of one versus two transcervical insertions of quinacrine pellets for sterilization. Fertil Steril. 2002; 77(5) 1065-1068
10 Sokal D C, Hieu T, Loan N D et al.. Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in Vietnam. Contraception. 2008; 78(1) 61-65
11 Lippes J. Quinacrine sterilization: the imperative need for American clinical trials. Fertil Steril. 2002; 77(6) 1106-1109
12 Benagiano G. An introduction to the supplement. Int J Gynaecol Obstet. 2003; 83 S1-S2
13 Clinicaltrials.gov .Available at: http://www.clinicaltrials.gov/ Accessed October 17, 2009
14 Kerin J F, Cooper J M, Price T et al.. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod. 2003; 18(6) 1223-1230
15 Cooper J M, Carignan C S, Cher D, Kerin J F. Selective Tubal Occlusion Procedure 2000 Investigators Group . Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. 2003; 102(1) 59-67
16 Sinha D, Kalathy V, Gupta J K, Clark T J. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation. BJOG. 2007; 114(6) 676-683
17 Shavell V I, Abdallah M E, Diamond M P, Berman J M. Placement of a permanent birth control device at a university medical center. J Reprod Med. 2009; 54(4) 218-222
18 Ubeda A, Labastida R, Dexeus S. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril. 2004; 82(1) 196-199
19 Levie M D, Chudnoff S G. Prospective analysis of office-based hysteroscopic sterilization. J Minim Invasive Gynecol. 2006; 13(2) 98-101
20 Arjona J E, Miño M, Cordón J, Povedano B, Pelegrin B, Castelo-Branco C. Satisfaction and tolerance with office hysteroscopic tubal sterilization. Fertil Steril. 2008; 90 1182-1186
21 Levy B, Levie M D, Childers M E. A summary of reported pregnancies after hysteroscopic sterilization. J Minim Invasive Gynecol. 2007; 14(3) 271-274
22 Veerseema S, Vleugels M P, Moolenaar L M, Janssen C A, Brölmann H A. Unintended pregnancies after Essure sterilization in the Netherlands. Fertil Steril. 2008; , November 20 (Epub ahead of print)
23 Hastings-Tolsma M, Nodine P, Teal S B, Embry J. Pregnancy outcome after transcervical hysteroscopic sterilization. Obstet Gynecol. 2007; 110(2 Pt 2) 504-506
24 Ory E M, Hines R S, Cleland W H, Rehberg J F. Pregnancy after microinsert sterilization with tubal occlusion confirmed by hysterosalpingogram. Obstet Gynecol. 2008; 111(2 Pt 2) 508-510
25 Moses A W, Burgis J T, Bacon J L, Risinger J. Pregnancy after Essure^® placement: report of two cases. Fertil Steril. 2008; 89(3) e9-e11(3)
26 Ploteau S, Lopes P. Pregnancy after hysteroscopic tubal sterilization despite two hysterosalpingograms showing bilateral occlusion. Eur J Obstet Gynecol Reprod Biol. 2009; 147(2) 238-239
27 Duffy S, Marsh F, Rogerson L et al.. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG. 2005; 112(11) 1522-1528
28 Baxter N, Hudson H, Rogerson L, Duffy S. Hysteroscopic sterilisation: a study of women's attitudes to a novel procedure. BJOG. 2005; 112(3) 360-362
29 Famuyide A O, Hopkins M R, El-Nashar S A et al.. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc. 2008; 83(4) 431-438
30 Levie M D, Chudnoff S G. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol. 2005; 12(4) 318-322
31 Hopkins M R, Creedon D J, Wagie A E, Williams A R, Famuyide A O. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation. J Minim Invasive Gynecol. 2007; 14(1) 97-102
32 Thiel J A, Carson G D. Cost-effectiveness analysis comparing the Essure tubal sterilization procedure and laparoscopic tubal sterilization. J Obstet Gynaecol Can. 2008; 30(7) 581-585
33 Franchini M, Cianferoni L, Lippi G et al.. Tubal sterilization by laparoscopy or hysteroscopy: which is the most cost-effective procedure?. Fertil Steril. 2009; 91(4, suppl) 1499-1502
34 Kraemer D F, Yen P Y, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception. 2009; 80(3) 254-260
35 Shavell V I, Abdallah M E, Diamond M P, Kmak D C, Berman J M. Post-Essure hysterosalpingography compliance in a clinic population. J Minim Invasive Gynecol. 2008; 15(4) 431-434
36 Shavell V I, Abdallah M E, Shade Jr G H, Diamond M P, Berman J M. Trends in sterilization since the introduction of Essure hysteroscopic sterilization. J Minim Invasive Gynecol. 2009; 16(1) 22-27
37 Nichols M, Carter J F, Fylstra D L, Childers M. Essure System U.S. . A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room. J Minim Invasive Gynecol. 2006; 13(5) 447-450
38 Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter shtudy of 495 patients. Fertil Steril. 2008;
39 Lett C D, Thiel J A. The effect of menstrual phase and hormonal contraception on successful bilateral placement of the Essure micro-insert tubal coil. Gynecol Surg. 2009; 6 219-222
40 Agostini A, Crochet P, Petrakian M, Estrade J P, Cravello L, Gamerre M. Hysteroscopic tubal sterilization (Essure) in women with an intrauterine device. J Minim Invasive Gynecol. 2008; 15(3) 277-279
41 Connor V F. Essure: a review six years later. J Minim Invasive Gynecol. 2009; 16(3) 282-290
42 Valle R F, Valdez J, Wright T C, Kenney M. Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety. Fertil Steril. 2006; 86(1) 152-158
43 Donnadieu A C, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation. Int J Gynaecol Obstet. 2007; 97(2) 139-142
44 Jansen N E, Vleugels M PH, Kluivers K B, Vierhout M E. Bilateral cornual abscess after endometrial ablation following Essure sterilization. J Minim Invasive Gynecol. 2007; 14(4) 509-511
45 Vancaillie T G, Anderson T L, Johns D A. A 12-month prospective evaluation of transcervical sterilization using implantable polymer matrices. Obstet Gynecol. 2008; 112(6) 1270-1277
46 FDA Summary of Safety and Effectiveness Data .Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf7/P070022b.pdf Accessed October 16, 2009
47 Adiana^® Permanent Contraception—Adiana and NovaSure^® Web site. Available at: http://www.adiana.com/hcp/adiana_novasure/adiana-novasure-serial-use.html Accessed October 16, 2009

Paula M CastañoM.D. M.P.H.

Assistant Clinical Professor, Department of Obstetrics and Gynecology, Columbia University Medical Center

622 W 168th St., PH 16-69, New York, NY 10032

Email: pc2137@columbia.edu